Showing results (51-60 of 114) with videos related to
Sort By:
Pageof 12
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2004
[Weekly paclitaxel therapy is useful for gastric carcinoma as second-line chemotherapy]Hirozumi Mizuiri, Kazuhiro Yoshida, Katsuhiko Shimizu, et al.Clinical Journal of Gastroenterology|January 7, 2022
Pancreatic duct rupture associated with high-grade pancreatic intraepithelial neoplasia treated by radical resection: a case reportRyuta Shintakuya, Toshihiko Kohashi, Naruhiko Honmyo, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2010
[Adjuvant surgery for advanced gastric cancer]Junya Taomoto, Kazuaki Tanabe, Takahisa Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 28, 2005
[Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1]Takahisa Suzuki, Kazuhiro Yoshida, Kazuaki Tanabe, et al.International Journal of Surgery Case Reports|August 31, 2017
Mixed adenoneuroendocrine carcinoma of the distal bile duct: A case reportToshiaki Komo, Toshihiko Kohashi, Akira Nakashima, et al.Anticancer Research|July 31, 2013
Treatment outcomes and prognostic factors for thoracic esophageal cancer with clinical evidence of adjacent organ invasionYoichi Hamai, Jun Hihara, Manabu Emi, et al.Anticancer Research|October 7, 2017
Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell CarcinomaYoichi Hamai, Jun Hihara, Manabu Emi, et al.ANZ Journal of Surgery|June 28, 2021
How to do it: endovascular stent and ligament resection during pancreaticoduodenectomy for coeliac axis stenosis in median arcuate ligament syndromeRyuta Shintakuya, Toshihiko Kohashi, Akira Nakashima, et al.Anticancer Research|September 9, 2018
Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic EsophagusTakaoki Furukawa, Yoichi Hamai, Jun Hihara, et al.Cancer Letters|October 1, 2008
EMP3 as a tumor suppressor gene for esophageal squamous cell carcinomaShoichi Fumoto, Keiko Hiyama, Keiji Tanimoto, et al.Pageof 12